Neurofibroma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) |
Sara Mohsin (talk | contribs) |
||
Line 5: | Line 5: | ||
Neurofibroma must be differentiated from [[schwannoma]], [[dermatofibrosarcoma protuberans]] (DFSP), [[ganglioneuroma]], and [[melanocytic nevus]]. | Neurofibroma must be differentiated from [[schwannoma]], [[dermatofibrosarcoma protuberans]] (DFSP), [[ganglioneuroma]], and [[melanocytic nevus]]. | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
[[Neurofibroma]] must be differentiated from:<ref name="libre">Neurofibroma. Libre Pathology 2015. http://librepathology.org/wiki/index.php/Neurofibroma#cite_note-pmid15486243-2 Accessed on November 17, 2015 </ref> | [[Neurofibroma]] must be differentiated from:<ref name="libre">Neurofibroma. Libre Pathology 2015. http://librepathology.org/wiki/index.php/Neurofibroma#cite_note-pmid15486243-2 Accessed on November 17, 2015 </ref><ref>http://surgpathcriteria.stanford.edu/peripheral-nerve/neurofibroma/</ref> | ||
* [[Schwannoma]] | * [[Schwannoma]] | ||
* [[Dermatofibrosarcoma protuberans]] (DFSP) | * [[Dermatofibrosarcoma protuberans]] (DFSP) |
Revision as of 19:54, 29 March 2019
Neurofibroma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neurofibroma differential diagnosis On the Web |
American Roentgen Ray Society Images of Neurofibroma differential diagnosis |
Risk calculators and risk factors for Neurofibroma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2] Shanshan Cen, M.D. [3]
Overview
Neurofibroma must be differentiated from schwannoma, dermatofibrosarcoma protuberans (DFSP), ganglioneuroma, and melanocytic nevus.
Differential Diagnosis
Neurofibroma must be differentiated from:[1][2]
- Schwannoma
- Dermatofibrosarcoma protuberans (DFSP)
- Ganglioneuroma
- Melanocytic nevus
- Myxoid liposarcoma
- Solitary circumscribed neuroma (palisaded encapsulated neuroma)
- Traumatic neuroma
- Neurotized nevus
- Superficial angiomyxoma
- Nerve sheath myxoma
- Malignant peripheral nerve sheath tumor (MPNST): has marked atypia and increased mitotic activity, may have necrosis
- Spindle cell lipoma
- Leiomyoma: has cigar-shaped nuclei, S100 negative, positive for smooth muscle actin and desmin
- Inflammatory myofibroblastic tumor: reactive spindle cells in inflammatory background
Disease entity | Etiology (Genetic or other) | Histopathological findings | Immunohistochemical staining | Benign/Malignant | Risk factors | Common site of involvement | Clinical manifestations | Other associated features |
---|---|---|---|---|---|---|---|---|
Neurofibroma |
Neurofibroma with degenerative atypia ("ancient change") has following microscopic features:
|
Positive for:
|
|
|
| |||
Schwannoma |
|
Positive for:
|
|
| ||||
Palisaded encapsulated neuroma | ||||||||
Traumatic neuroma | ||||||||
Neurotized Melanocytic Nevus | ||||||||
Cutaneous Myxoma (Superficial angiomyxoma) | ||||||||
Nerve sheath myxoma | ||||||||
Malignant peripheral nerve sheath tumor | ||||||||
Dermatofibrosarcoma protuberans (DFSP) | ||||||||
Spindle cell lipoma |
References
- ↑ Neurofibroma. Libre Pathology 2015. http://librepathology.org/wiki/index.php/Neurofibroma#cite_note-pmid15486243-2 Accessed on November 17, 2015
- ↑ http://surgpathcriteria.stanford.edu/peripheral-nerve/neurofibroma/